Purpose-Structural and compositional heterogeneity within drusen, composed of lipid, carbohydrates, and proteins, have been previously described. We sought to detect and define phenotypic patterns of drusen heterogeneity in the form of optical coherence tomographyreflective drusen substructures (ODS) and examine their associations with age-related macular degeneration (AMD)-related features and AMD progression.
have shown that other drusen-related features, such as drusen volume and hyperreflective foci above drusen, predict progression to GA. 14, 15 We thus hypothesized that patterns within drusen, or optical coherence tomography-reflective drusen substructures (ODS), in eyes with AMD may confer risk of GA progression and would provide additional insight into individual risk of AMD progression.
In this study, we evaluated eyes with intermediate AMD from the prospective Age Related Eye Disease Study 2 (AREDS2) Ancillary SD OCT Study for the presence of ODS in the macula and classified each ODS into 4 phenotypic subtypes. We examined the relationships between ODS and AMD-related features visible on SD OCT and color photograph crosssectionally and longitudinally. In addition, we sought to learn whether any apparent effect of ODS was exerted primarily in the local area of the ODS or found more generally across the entire macula.
Methods
All participants were enrolled in the AREDS2 (ClinicalTrials.gov identifier NCT00345176) and consented to participate in the AREDS2 Ancillary SD OCT (A2A SD OCT, ClinicalTrials.gov identifier NCT00734487) study. The study was approved by the Institutional Review Board at each of 4 clinical sites. Informed written research consent was obtained before participation from each study participant, and the research protocol followed tenets of human research as presented in the Declaration of Helsinki. Data were collected, stored, and managed in compliance with Health Insurance Portability and Accountability Act guidelines.
Study Design and Procedures
The A2A SD OCT study design has been described in previous work. 13 The participating sites recruited 349 participants aged 50 to 85 years with at least 1 intermediate AMD eye. Intermediate AMD eyes were defined as eyes containing at least 1 large drusen (diameter ≥125 μm), but no central GA or neovascularization. The study eyes could contain GA that did not involve the foveal center, consistent with the AREDS2 definition of Category 3 AMD. 16 At the time of baseline imaging in the A2A Study, 32 were excluded for bilateral advanced AMD and 10 were excluded for poor image quality. The remaining 307 eyes were enrolled in the study, and data on age, smoking status, and statin use for each participant were collected at study baseline. 16 At baseline and each annual study visit, the participant received a comprehensive eye examination including best-corrected visual acuity and ocular imaging conducted by certified personnel using standardized protocol for color photographs and SD OCT. 13 The SD OCT imaging was with the Bioptigen SD OCT imaging system (SDOIS; Bioptigen, Research Triangle Park, NC). As previously reported, 2 raster scans, consisting of 100 B-scan lines separated by 66 μm between lines and consisting of 1000 Ascans per line oriented at 0° and 90°, generated SD OCT volumes for each eye. Each scan volume covered an area of 6.7 × 6.7 mm 2 and was centered on the fovea.
Certified graders analyzed SD OCT volume scans of study eyes for the presence of 1 or more ODS. For scans that were designated as having ODS, 4 graders (M.V., A-K.M.E-H.S., K.P.W., M.M.) independently scanned each frame to phenotypically categorize each ODS into 4 subtypes based on reflectivity patters within drusen: H-type (high-reflective core), Ltype (low-reflective core), C-type (conical debris), and S-type (split drusen) ( Table 1 ). In cases of grading disagreement, the A2A SD OCT Chair (CAT) provided arbitration and final assignment. Although ODS as optical coherence tomography (OCT) findings were part of the original study design and grading, the 4 subtypes of ODS were designated and graded subsequent to that. This analysis was thus retrospective although in a prospective group.
Macula-wide Analysis-Eyes were divided into 2 main groups: those with and those without ODS at baseline. Further, eyes with each particular subtype of ODS were tabulated separately; eyes with more than 1 subtype of ODS were represented multiple times in subtype analyses. Study eyes with any ODS, as well as eyes with H-type, L-type, C-type, and S-type ODS, were each compared with the eyes without ODS with respect to AMDrelated features within the central 5-mm diameter macular region of each study eye at baseline, year 2, and year 3.
Regional Analysis-Within eyes with ODS, a region of interest (ROI) was defined as a circular area of 500 μm diameter around each individual ODS and positioned with the ODS at its center. In the same eye, a custom-designed program defined a control ROI of equal diameter for comparison, which was matched as closely as possible in distance from the foveal center and retinal pigment epithelium-drusen complex (RPEDC) volume. All control ROIs were at least 200 μm from each other and from ODS ROIs in the same eye. It was possible to have more than 1 ODS ROI per eye. For eyes with only 1 ODS, 1 ODS ROI and 1 control ROI were defined. For eyes with 2 or more ODS, only 2 ODS ROIs and 2 matching control ROIs were defined; these 2 pairs of ROIs were selected among candidate lesions on the basis of the closest match with respect to foveal distance and RPEDC volume. We used MATLAB software (MathWorks, Natick, MA) to register all ROIs from baseline onto the corresponding location in the SD OCT scan of each study eye at years 2 and 3, using the foveal center for alignment. The ROIs with any ODS, as well as ROIs with H-type, L-type, C-type, and S-type ODS, were each compared with corresponding ROIs without any ODS with respect to AMD-related features at baseline, year 2, and year 3. Individual ROIs whose limits extended beyond the 5-mm diameter macular region SD OCT scanning field under consideration were excluded in calculation of outcomes based on SD OCT segmentation, but included in the calculation of all other outcomes. This same regional analysis was repeated for control ROIs selected from eyes without ODS. In addition, we used the regional methods to study ROIs 2 years before new-onset ODS to determine any precursor lesions in the location of new-onset ODS.
To evaluate for AMD-related features in color photographs within ODS, we registered ODS ROIs at baseline from SD OCT to their corresponding location on color photographs using a customized MATLAB software program. We graded each region for 1 or more of the following: hyperpigmentation, hypopigmentation (calcific drusen, crystalline drusen, or retinal pigment epithelium [RPE] atrophy), normal RPE, and normal drusen using the Wisconsin age-related maculopathy grading system. 17
Outcomes
The primary outcomes for the macula-wide analysis were GA, central GA and CNV on color photograph, and measures of preatrophy on SD OCT for the regional analysis, and these definitions are detailed in Table 2 . [16] [17] [18] [19] [22] [23] [24] [25] [26] Secondary outcomes were measures of drusen load and features associated with neovascularization, with definitions also detailed in Table 2 . Other subretinal lesions, hyperreflective foci above drusen, visual acuity, and neurosensory retina were also studied and detailed in Table 2 . 15, 20, 21 In an effort to study the evolution of ODS over time, ROIs at years 2 and 3 in the regional analysis were evaluated for persistence of baseline ODS and transformation of persistent ODS into different subtypes.
Data Analysis
Macula-wide Analysis-In a cross-sectional analysis, we compared outcomes at baseline in eyes with versus without ODS at baseline. Continuous outcomes were compared using the Wilcoxon rank-sum test, and binary outcomes were compared using the Fisher exact test. In a longitudinal analysis, changes in the continuous outcomes from baseline to year 2 and baseline to year 3 were compared between eyes with and without ODS at baseline using the Wilcoxon rank-sum test, whereas new onset of binary outcomes (defined as occurrence of the outcome in an eye that did not have it at baseline) from baseline to year 2 and baseline to year 3 were compared using the Fisher exact test.
Regional Analysis-In a cross-sectional analysis, we compared outcomes within ODS ROIs with those within paired control ROIs at baseline. Continuous variables were compared using the paired t test with generalized estimating equations (GEEs) to account for multiple regions in each eye, whereas binary variables were compared using the test for difference in proportions for matched pairs (McNemar's test). In a longitudinal analysis, changes in continuous outcomes from baseline to year 2 and baseline to year 3 were compared between ODS ROIs and paired control ROIs defined at baseline using the paired t test with GEE, whereas new onset of binary outcomes from baseline to year 2 and baseline to year 3 were compared using the McNemar's test. In the binary outcome analyses, we assumed for simplicity that the presence of 1 ODS is not linked to the presence of another. Thus, regions were treated independently, although some occurred in the same eye. In the regional analysis in which control ROIs were in non-ODS eyes, the ROIs were not paired. Thus, we used the GEE comparison of means for continuous variables and GEE comparison of proportions for binary variables to account for multiple regions in each eye.
Results
Among the 349 eyes enrolled in the A2A SD OCT Study, 307 eyes met the present study's inclusion criteria. The mean age of patients was 74.5 years (standard deviation, 7.5). Seventy-four eyes (24%) had at least 1 ODS in the macula, and 233 eyes (76%) had none. In the ODS group, mean age of patients was 75 years; 36% had never smoked, 57% were former smokers, and 7% were current smokers; 45% were using statins. In the non-ODS group, the mean age was 74 years; 44% had never smoked, 50% were former smokers, and 6% were current smokers; 52% were using statins. There were no significant differences in age, smoking, or statin use between the ODS and non-ODS groups.
Of the 74 ODS eyes, the mean number of ODS per eye at baseline was 2.7 (standard deviation, 2.5; min 1, med 2, max 17), and 29 (39%) had 1 ODS, 16 (22%) had 2 ODS, and 29 (39%) had 3+ ODS. The distribution of ODS subtypes in the 74 eyes was as follows: 49 (66%) had H-type cores, 41 (55%) had L-type cores, 16 (22%) had C-type debris, and 11 (15%) had S-type drusen.
Macula-wide Analysis
Cross-sectional analysis of AMD disease features at baseline with respect to baseline presence of ODS and ODS subtypes is shown in Table 3 . The ODS were associated with multiple SD OCT measures of greater drusen load: higher RPEDC volume on SD OCT (mean, 0.74 ODS vs. 0.67 no ODS, P < 0.001), higher OCT drusen volume on SD OCT (mean, 0.10 ODS vs. 0.08 no ODS, P < 0.001), and higher drusen area on color photograph (mean, 6.47 ODS vs. 6.01 no ODS, P < 0.001). The ODS were associated with RPE atrophy on SD OCT (43.24% ODS vs. 16.38% no ODS, P < 0.001), especially within 660 μm of the foveal center (20.27% ODS vs. 7.33% no ODS, P = 0.004), but not with GA and preatrophy measures at baseline. None of the eyes had central GA or CNV at baseline (these were exclusion criteria). The ODS were not associated with typically neovascular SD OCT features at baseline, except intraretinal fluid (IRF) (24.32% ODS vs. 13.91% no ODS, P = 0.047).
Other subretinal lesions (reticular pseudodrusen, subretinal hyperreflective material, vitelliform lesion, scar, and hemorrhage), hyperreflective foci, visual acuity, and neurosensory retina were additional outcomes studied. The ODS were not associated with lower visual acuity at baseline. However, among subtypes, C-type lesions were associated with lower visual acuity (P = 0.03) at baseline. Last, 59 of 74 ODS eyes (79.7%) had hyperreflective foci at baseline versus 121 of 233 non-ODS eyes (51.9%) with this feature (P < 0.001). Table 4 summarizes the longitudinal analyses of outcomes at year 2, with respect to baseline presence of ODS and ODS subtypes. The ODS at baseline were not associated with drusen load outcomes at year 2. With regard to GA and preatrophy outcomes, ODS at baseline were associated with increase in retinal pigment epithelium drusen complex abnormal thinning (RAT) volume on SD OCT (mean, 1.91 ODS vs. 0.55 no ODS, P = 0.01) and increase in area of GA on color photographs (mean, 0.41 ODS vs. 0.08 no ODS, P = 0.006) at year 2.
The ODS at baseline also were associated with new-onset photoreceptor layer (PRL) thinning (28.07% ODS vs. 9.79% no ODS, P = 0.002), RPE disruption (20.97% ODS vs. 9.80% no ODS, P = 0.03), and RPE atrophy (28.21% ODS vs. 8.99% no ODS, P = 0.003), especially within 660 μm of the foveal center (P = 0.03), all on SD OCT at year 2. Although ODS presence at baseline was associated with multiple SD OCT measures of GA and atrophy, ODS presence at baseline was not associated with new onset of central GA or any GA on color photograph (primary study outcomes) at year 2. However, among subtypes, Ctype at baseline was associated with new-onset GA at year 2 (P = 0.009). The ODS at baseline were not associated with new onset of CNV (primary study outcome) or of typically foci, or change in visual acuity at year 2, and were associated with a smaller decrease in neurosensory retina volume (P = 0.003). In examining the subtypes, conical debris were associated with lower average RPEDC and OCT drusen volumes at baseline and greater decrease in RPEDC at year 2, suggesting collapse and subsequent atrophy. Although all 4 subtypes were associated with RPE atrophy at baseline, conical debris were additionally trending toward larger RAT volume and GA size. At year 2, conical debris was associated with the highest number of atrophic measures, followed by high-reflective cores, split drusen, and low-reflective cores. The results were similar in the year 3 data.
Analysis of Covariance-Retinal pigment epithelium drusen complex volume, OCT drusen volume, and drusen area were associated with ODS as baseline. Thus, we conducted an analysis of covariance for these outcomes and found that none were significantly associated with year 2 and year 3 outcomes, except drusen area with new GA at year 3. The ODS remained significantly associated with outcomes in years 2 and 3 after adjustment for covariates. We did not adjust for age, statin, or smoking in the longitudinal portion of the study because we found no significant difference between the ODS group and no ODS group with regard to these variables at baseline.
Regional Analysis
Within 
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Author Manuscript (8.16%) were characterized as having calcific drusen, 8 (8.16%) were characterized as RPE atrophy, and 2 (2.04%) were characterized as crystalline drusen. Four ODS ROIs had both hyperpigmentation and hypopigmentation. Because of a question as to whether C-type might represent calcific or crystalline drusen on color photographs, we performed a post hoc (Appendix 1, available at www.aaojournal.org) analysis of the C-type ROIs on color photograph, which were 15 of the 98 ODS ROIs studied. Normal RPE was observed in 10 of 15 (66.7%), normal drusen were observed in 10 of 15 (66.7%), hyperpigmentation was observed in 2 of 15 (13.3%), and hypopigmentation was observed in 4 of 15 (26.7%).
In an examination of autofluorescence images (7 eyes), the locations corresponding to 31 randomly selected ODS were found to lack a particularly distinct appearance compared with the background surrounding pattern of fluorescence. The most common finding in ODS locations was an absence of hyper-autofluorescence, fluorescence patterns, and hypofluorescence. The prevailing mottled pattern of background autofluorescence contributed to difficulties in identifying the patterns at ODS locations. On infrared images (3 eyes), we were unable to determine whether there exists a correlation because ODS locations did not appear to have distinct features compared with surrounding areas.
Cross-sectional analysis of baseline regions with respect to the presence or absence of ODS and ODS subtypes is shown in Table 6 . The ODS were not associated with regional OCTderived drusen load outcomes. With regard to preatrophy outcomes (primary study outcomes) at baseline, ODS were associated with regional PRL thinning without drusen (12.28% ODS vs. 4.39% no ODS, P = 0.02) and increased choroidal signal (23.68% ODS vs. 13.16% no ODS, P = 0.03), with a trend toward PRL thinning above drusen and ellipsoid zone loss. The ODS were not associated with typically neovascular regional outcomes IRF, SRF, and other subretinal lesions (reticular pseudodrusen, subretinal hyperreflective material, vitelliform lesion, scar, hemorrhage) at baseline. The ODS were associated with baseline presence of hyperreflective foci above drusen (45.61% ODS vs. 16 .67% no ODS, P < 0.001).
Substructures demonstrated a dynamic nature, disappearing, persisting as the same subtype, or spontaneously converting into a different subtype. Of 114 ODS within ROIs at baseline, 31 (27.2%) persisted at year 2 and 17 (14.9%) persisted at year 3. Figure 1 summarizes their evolution over time. In contrast, of the 114 control ROIs, 5 had ODS at year 2 and 9 had ODS at year 3, with an assortment of subtypes.
Longitudinal analysis of regional AMD disease progression at year 2 with respect to baseline presence or absence of ODS and ODS subtypes is shown in Table 7 . With respect to preatrophy outcomes at year 2, new onset of regional PRL thinning without drusen (16.87% ODS vs. 7.23% no ODS, P = 0.02) and ellipsoid zone loss (66.67% ODS vs. 33.33% no ODS, P = 0.046) were both greater in ROIs with ODS versus without ODS at baseline. The ODS were not associated with regional OCT-derived drusen load outcomes or with new onset of typically neovascular regional outcomes IRF, SRF, and other subretinal lesions at year 2. 
Longitudinal analysis of regional AMD disease progression at year 3 with respect to baseline presence or absence of ODS and ODS subtypes is shown in Table 8 (available at www.aaojournal.org). With respect to preatrophy outcomes at year 3, new onset of regional PRL thinning without drusen (27.03% ODS vs. 13.51% no ODS, P = 0.008) and RPE atrophy (20.97% ODS vs. 9.68% no ODS, P = 0.04) were both greater in ROIs with ODS versus without ODS at baseline. The ODS were not associated with regional OCT-derived drusen load outcomes or with new onset of typically neovascular regional outcomes IRF, SRF, and other subretinal lesions at year 3.
Results for the unpaired regional analysis in which control ROIs were selected in non-ODS eyes are presented in Tables 9 to 11 (available at www.aaojournal.org). In our additional study of precursor lesions in the location 2 years before new-onset ODS, we compared 71 ODS precursor regions with 71 control precursor regions. New-onset ODS was preceded only by RPE elevation (86.59% ODS vs. 63.41% no ODS, P < 0.001) and RPE atrophy (58.54% ODS vs. 36.59% no ODS, P = 0.001).
Discussion
In this study, we introduce ODS as an OCT-based clinical entity in intermediate AMD and report its association with disease progression. Although ODS are visible on SD OCT, the retinal positions that they occupy cannot be distinguished from surrounding areas on color fundus photography and are typically located amidst drusen and normal RPE. We demonstrate that ODS are lesions predictive of accelerated progression to advanced stages of atrophic AMD identifiable on SD OCT over 3 years. The presence of ODS at baseline was not found to be associated with change in visual acuity or development of CNV. The association with the development of atrophic changes was shared between multiple forms of ODS but was largest for the conical debris subtype of ODS.
In the analysis of outcomes related to drusen load, we found that ODS tended to present in maculae with greater total drusen volume and drusen area, relative to maculae that lack ODS. However, the ODS themselves were not located in individual drusen of larger volume.
In the macula-wide analysis of outcomes associated with atrophic features, eyes with ODS at baseline were significantly associated with new onset of PRL thinning, greater increase in RAT, and faster growth of existing GA at years 2 and 3, and new onset of GA at year 3. In the regional analysis of atrophy, ODS were associated with local preatrophic features at baseline (PRL thinning, increased choroidal signal). Longitudinally, ODS were also associated locally with new onset of PRL thinning and ellipsoid zone loss at year 2 and new onset of PRL thinning and RPE atrophy at year 3. Taken together, the occurrence of ODS on a macula-wide scale appears to emerge in the later "life cycle" stages of non-neovascular AMD in which drusen accumulation is followed by drusen regression and subsequent atrophy (Fig 2) . 27 On a regional scale, the ODS themselves may be located in areas of regressing drusen and nearby atrophy ( Fig 3) . As such, ODS may represent a phenotype manifest in drusen just before, or are in the initial phase of, overt regression. are not preceded by any unique lesions. Longitudinal observation of ODS found that a majority of ODS that were present at baseline were no longer apparent at years 2 and 3 at the same locus. Even among persisting ODS lesions, the morphologic features of the ODS were observed to change with time and often resulted in reclassification into a different subtype from that scored at baseline. Most split drusen and low-reflective core ODS subtypes transitioned to high-reflective cores, and most high-reflective cores, the most commonly persistent among the 4 subtypes, transformed into conical debris. It is possible that ODS subtype transitions tend to follow the above order and then disappear with drusen regression, and represent progressive change in drusen substructure leading to drusen regression. Consistent with this, an analysis of subtypes revealed that the conical debris is associated with the most rapid progression to atrophy, followed by high-reflective cores, split drusen, and low-reflective cores. The difference in disease impact between the conical debris and the remaining subtypes was significant, whereas the differences within the remaining subtypes were minor. A post hoc analysis did not reveal any focal color photographic correlates for conical debris.
One question that arises as a result of this study relates to the structural basis of ODS. In a prior study, we reported that hyperreflective foci on SD OCT at the inner margin and above RPE predict progression to GA. 15 This study demonstrated a significant macula-wide and regional cooccurrence of ODS and hyperreflective foci (79.7% of ODS eyes had hyperreflective foci at baseline vs. 51.9% non-ODS eyes, P < 0.001, and 45.61% ODS ROIs had hyperreflective foci at baseline vs. 16 .67% non-ODS ROIs, P < 0.001). However, it is unlikely that ODS and hyperreflective foci are manifestations of the same type of cellular change. We previously speculated that hyperreflective foci represent RPE cells migrating into the inner nuclear and inner plexiform layers of the retina, or alternatively, microglial cells. Optical coherence tomography-reflective drusen substructures, in contrast, do not appear to originate from the RPE layer, are located below the RPE monolayer within drusen themselves, and do not progress to hyperreflective foci at the same location. They are also more transient than hyperreflective foci, which often persist over 2 or more years. Optical coherence tomography-reflective drusen substructures are variable in size and shape and more likely a reflection of heterogeneity in drusen composition and architecture observed in histologic studies. As such, although hyperreflective foci and ODS tend to be found together, they relate to distinct cellular and morphologic features in the AMD eye.
Previous histopathologic studies have described the presence of spherules within drusen, which in size and shape closely resemble the low-reflective and high-reflective core ODS subtypes observed in our study. Mullins and Hageman 9 first described "cores" as localized carbohydrate moieties within drusen, composed of glycoproteins with O-glycosidically linked carbohydrate chains. 28 Johnson et al 8 later demonstrated spherical vesicles within drusen that contain concentric ring or coiled structures on immunohistochemical analysis with amyloid β and amyloid precursor protein localized on the outer shell of the vesicle. Furthermore, they showed that these vesicles were immunopositive for immunoglobulin G, complement components C3b/5/C5b-9, and RPE pigment granules. 8, 29, 30 Anderson et al 7 found that the small spherules within drusen are immunoreactive for apolipoprotein E, which is upregulated by Müller glia cells in the degenerating human retina affected by AMD. 31 The existence of both immunomodulators and molecules from inside RPE cells in 
Author Manuscript
Author Manuscript these drusen spherules strongly suggests their formation is a result of immune-mediated RPE cell pathology in AMD and that they are biologically active sites in atrophy pathogenesis. 31, 32 The striking association between ODS and advancement of AMD leads us to suggest that these ODS could be the spherules described in these previous AMD histopathologic studies. Because SD OCT is an imaging modality based on reflectivity of light, the heterogeneous and nonuniform composition of drusen may give rise to patterns of different reflectivity that constitute ODS. Low reflective cores may consist primarily of lipids, whereas high reflective cores may consist primarily of proteins and hydroxyapatite (calcium derivative). 33 Conical debris may be calcific deposits throughout drusen caused by a shattering of high reflective cores. Split drusen may simply be a heterogeneously composed drusen, with diseaseassociated molecules that have not seeded onto spherules.
Two previous studies reported on drusen substructures on OCT. In a cross-sectional study of 25 eyes, Schlanitz et al 34 used polarization-sensitive OCT to demonstrate the existence of cores within drusen and their association with drusen of larger diameter. Suzuki et al 35 identified refractile drusen on SD OCT, defined as drusenoid material with small refractile spherules and similar in appearance to the conical debris we have described in this study. In a cross-sectional analysis, it was found that the 14 study eyes with refractile drusen were associated with loss of RPE on autofluorescence. 35 Our study is unique in its robust size, analysis of different subtypes of drusen substructures, number of AMD outcomes studied, and analysis of the longitudinal impact of ODS on disease progression.
Study Limitations
Study limitations included a small number of eyes with ODS, especially for within each group of ODS subtypes; however, this should be expected for a relatively rare OCT feature. We were limited to 3 years of follow-up. Registration of ROIs from baseline to follow-up years may have introduced error due to varying orientations of SD OCT volumes for the same subject across different years and location limitations due to fixed B-scan increments. Last, the grading of ODS described in this study on high density (67 μm/B-scan) volume scans was compared with independent repeat grading for 44 randomly selected ODS registered on ultra-high density (16.5 μm/B-scan) volume scans (13 eyes) captured on the same day as the high-density scans. For regional presence of ODS, the 2 scans agreed in 89% of drusen and the agreement was substantial (Cohen's kappa κ = 0.601, P < 0.001). 36 With the exception of split drusen with fair agreement (κ=0.39, P = 0.006) at 89%, the ODS subtypes had moderate agreement at 91% for conical debris (κ = 0.55, P < 0.001), 77% for high-reflective cores (κ=0.54, P < 0.001), and 86% for low-reflective cores (κ = 0.55, P < 0.001). Reasons for disagreement may include the inability to capture the same location of ODS on ultra-high density scans.
Optical coherence tomography-reflective drusen substructures are biomarkers of AMD disease progression. The exact pathogenesis of AMD is unknown, so precise characterization of early lesions and their evolution over time can provide insight into pathophysiology and guide research on treatments. 2, 3, 27, 37 Follow-up studies will include an analysis of precursors to ODS, which may help us identify earlier lesions that are predictive 
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Author Manuscript of disease progression. Previous studies have reported that hyporeflective and hyperreflective drusen, as well as hyperreflective foci, may play an important role in predicting AMD disease progression. 13, 15 These SD OCT features along with the ODS described in this article represent a family of clinical characteristics that play an important role in predicting GA. We plan to conduct an analysis of this family of SD OCT features to determine their association with each other and compare their predictive power in AMD progression. It would also be worthwhile to explore the relationship between this SD OCT family of features and known AMD susceptibility genes, such as age-related maculopathy susceptibility 2 and a previously studied library of single nucleotide polymorphisms. 28, 38, 39 
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